End-stage renal disease (ESRD) is often complicated by the development of hyperparathyroidism (HPT); more than 80% of patients with a glomerular filtration rate (GFR) below 20 mL/min develop serum PTH levels exceeding the upper limit of normal [19]. This evidence concerns the gene PTH and hyperparathyroidism.